Our Faculty
GBS has access to a large network of highly qualified lecturers. When selecting lecturers for our programs, we value a solid academic foundation and many years of teaching and practical experience equally.
In addition to experts from the Faculty of Economics and Business Administration and the Faculty of Chemistry, Biochemistry and Pharmacy at Goethe University, the Pharma MBA also includes selected renowned practitioners from the pharmaceutical industry and the House of Pharma and Healthcare as lecturers.
The quality of a program’s faculty is crucial for its successful delivery and especially its students’ learning experience. Therefore, the Master of Pharma Business Administration faculty is carefully selected in consultation with our advisory board to best meet the requirements of each module – with a balanced mix of experienced academics and practitioners to ensure the high practical relevance of the content we deliver.
Overview
| Name | |
|---|---|
 | Dr. Frank Behrens Head of Department, Clinical Research Fraunhofer Institute for Molecular Biology and Applied Ecology IME |
 | Susanna Dienemann Partner Wachenhausen Rechtsanwälte, Lübeck |
 | Prof. Dr. Theo Dingermann Institut für Pharmazeutische Biologie Goethe University |
 | Prof. Guido Friebel, Ph.D. Chair of Human Resource Management Goethe University |
 | Prof. Martin Götz, Ph.D. SAFE Chair of Regulation and Stability of Financial Institutions Goethe University |
 | Dr. Marcus Gollub Head of Commercial Excellence EMEA Merz Pharmaceuticals GmbH |
 | Dr. Peter Greiner Regional Business Lead Fertility EMEA Merck Group |
 | Dr. Ingolf Griebsch Head of Corporate Market Access Oncology/Functional Lead Health Economics & Outcomes Boehringer Ingelheim Pharma GmbH & Co. KG |
 | Dr. Andreas Henschel Head of Center of Excellence Health Technology Assessment Boehringer Ingelheim Pharma GmbH & Co. KG |
 | Nora Keßler Fachanwältin für gewerblichen Rechtsschutz, Partnerin Klinkert Rechtsanwälte |
 | Dr. Edmund Kostewicz Institute of Pharmaceutical Technology Goethe University |
 | Dr. Stephan Linden Associate Healthe Economics & Outcomes Research Manager Boehringer Ingelheim Pharma GmbH & Co. KG |
 | Dr. Ralf Mayr-Stein Head of Health Policy & Market Access Mylan |
 | Prof. Dr. Klaus Miller Assistant Professor of Quantitative Marketing |
 | Prof. Dr. Michael Parnham Head of Preclinical Research, Project Group Translational Medicine and Pharmacology Fraunhofer IME |
 | Dr. Matthias Pfannkuche Director Market Access & Government Affairs Merck Serono GmbH |
 | Dr. Martin Raditsch CEO Innovectis GmbH |
 | Dipl. Psych./M. Sc. Justine Rochon Head of Biostatistics and Data Sciences (Europe) Boehringer Ingelheim Pharma GmbH & Co. KG |
 | Prof. Dr. Anna Rohlfing-Bastian Chair for Accounting, esp. Management Accounting Goethe University |
 | Dr. Markus Rudolph Managing Director InfectoPharm Arzneimittel und Consilium GmbH |
 | Dr. Sebastian Schäfer Managing Director TechQuartier |
 | Dr. Ursula Schickel Senior Director, Customer Onsite Support, Head of Regulatory Affairs Team (Mannheim) PharmaLex GmbH |
 | Dr. Olaf Schickling Senior Director, Head of Pharmacovigilance PharmaLex GmbH |
 | Prof. Dr. Manfred Schubert-Zsilavecz Institut für Pharmazeutische Chemie Vizepräsident, Goethe-Universität |
 | Dr. Hans-Martin Schwarm Senior Advisor Pharma & Health Care |
 | Prof. Dr. Lars Schweizer UBS-Chair of Strategic Management Goethe University |
 | Dr. Diane Seimetz Founding Partner Biopharma Excellence |
 | Dr. Heike Streu |
 | Prof. Dr. Yvonne Thorhauer Center for Business Ethics Goethe University |
 | Dr. Jonathan Trethowan Vice President Regulatory and Scientific Policy PharmaLex GmbH |
 | Prof. Dr. Rolf van Dick Chair of Social Psychology and Head of Social Psychology Department Goethe University |
 | Dr. Matthias Wacker |
 | Dr. rer. nat. Claus Weichel TA Head Immunology Europa UCB Pharma GmbH |
 | Dr. Martin Weiser Hauptgeschäftsführer Bundesverband der Arzneimittel-Hersteller e.V. |
 | Prof. Dr. Simone Wies SAFE Juniorprofessur für Marketing und Finance Goethe University |